Page 109 | Certara

Blog

How Biosimulation & AI Tech Could Solve Pharma’s R&D Productivity Crisis

Drug development continues to be painfully slow and mind-bogglingly expensive. In a 2010 article, Stephen…

CertaraOctober 27, 2023

Blog

Chemical Data Migration best practices – Stage 2: Data Curation

How to make existing data - chemical structures along with their additional data - compliant…

CertaraOctober 26, 2023

Blog

Automated model building using only relevant features

Accelerate your drug discovery process: Create multiple models effortlessly with Trainer Engine and increase your…

CertaraOctober 26, 2023

Brochure

Certara QSP Designer Technology

User-driven, graphical workspace to optimize collaboration for all stakeholders

CertaraOctober 25, 2023

Blog

Authoring & Assembling IND and CTA Applications – Insights and Updates

Investigational New Drug Applications (INDs) and Clinical Trial Applications (CTAs) are regulatory submissions needed for…

CertaraOctober 23, 2023

Blog

Advancing Rectal Drug Delivery: A Breakthrough in Physiologically Based Pharmacokinetic Modeling

This blog explains how Certara’s Simcyp team developed and tested a model in the Simcyp…

CertaraOctober 20, 2023

On-Demand Webinar

RAPS Sponsored Webcast: Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned

As the drug development industry strives to accelerate submission timelines and improve patient access to…

CertaraOctober 18, 2023

Blog

10 Things to Know About eCTD 4.0: Embracing the Future Regulatory Submissions

In this blog post, we explore the top 10 things you need to know about…

CertaraOctober 17, 2023

On-Demand Webinar

AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

The development of new drugs for rare diseases is a challenging process due to small…

CertaraOctober 12, 2023

Press Release

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraOctober 11, 2023

How Biosimulation & AI Tech Could Solve Pharma’s R&D Productivity Crisis

Chemical Data Migration best practices – Stage 2: Data Curation

Automated model building using only relevant features

Certara QSP Designer Technology

Authoring & Assembling IND and CTA Applications – Insights and Updates

Advancing Rectal Drug Delivery: A Breakthrough in Physiologically Based Pharmacokinetic Modeling

RAPS Sponsored Webcast: Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned

10 Things to Know About eCTD 4.0: Embracing the Future Regulatory Submissions

AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

Newsletter sign up

Quick links

Solutions

Contact